This is a community-generated profile. If you would like to claim it, please .
Endotronix Funding
Endotronix is active in the following markets / industries: biotechnology. The company has secured funding across 4 rounds and is valued at $0. Their most recent funding was raised on July 14, 2016.
Funding Rounds
U
$1600000U
$1200000U
$1800000Investors of Endotronix
Founder, RTMS, Inc., now a unit of Fidelity Financial; Founder, Golden Angels Network; EdTech Investor (LP in OWL VC); Director, First Business (FBIZ:Nasdaq)
JumpStart Inc.
Global commercial banking fueling today’s innovators, entrepreneurs and investors
Nick Mourlas
New Ventures @Johnson & Johnson Innovation. Past CEO, Tarsus Medical (acquired: IART) & Acumen Medical (acquired: MDT). Stanford PhD & Biodesign Fellow
Lumira Capital
Rounds
C
Aperture Venture Partners
Rounds
C
Bioventures Investors
Rounds
C
SV Life Sciences
Rounds
C
Cornerstone Angels
